Morpholine → 1-{4-[4-(2-Morpholin-4-yl-5-nitro-benzoyl)-piperazin-1-yl]-phenyl}-ethanone

HRID 736182

Reaction equation

HRID 736182 reaction equation
F[C:2]1[CH:24]=[CH:23][C:22]([N+:25]([O-:27])=[O:26])=[CH:21][C:3]=1[C:4]([N:6]1[CH2:11][CH2:10][N:9]([C:12]2[CH:17]=[CH:16][C:15]([C:18](=[O:20])[CH3:19])=[CH:14][CH:13]=2)[CH2:8][CH2:7]1)=[O:5].[NH:28]1[CH2:33][CH2:32][O:31][CH2:30][CH2:29]1>>[N:28]1([C:2]2[CH:24]=[CH:23][C:22]([N+:25]([O-:27])=[O:26])=[CH:21][C:3]=2[C:4]([N:6]2[CH2:11][CH2:10][N:9]([C:12]3[CH:17]=[CH:16][C:15]([C:18](=[O:20])[CH3:19])=[CH:14][CH:13]=3)[CH2:8][CH2:7]2)=[O:5])[CH2:33][CH2:32][O:31][CH2:30][CH2:29]1

Participants

3

Procedure

The title compound was prepared according to the procedure described for example 1 from 1-{4-[4-(2-Fluoro-5-nitro-benzoyl)-piperazin-1-yl]-phenyl}-ethanone and morpholine (85%, yellow solid, MS (m/e): 439.3 (M+H, 100%)

Sources & evidence

ORD record
ord-1375cec502574413bd9fa7c7c985e15e
Source dataset
uspto-grants-2009_09
Patent number
US07595314B2

Linked notes

Loading…